Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study
- PMID: 12038942
- DOI: 10.1001/archinte.162.11.1245
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study
Abstract
Objective: To assess the potential impact of controlling risk factors on the incidence of venous thromboembolism by estimating the population attributable risk (defined as the percentage of all cases of a disease in a population that can be "attributed" to a risk factor) for deep vein thrombosis and pulmonary embolism associated with venous thromboembolism risk factors.
Methods: Using data from a population-based, nested, case-control study of the 625 Olmsted County, Minnesota, residents with a definite first lifetime deep vein thrombosis or pulmonary embolism diagnosed during the 15-year period 1976 to 1990 and 625 unaffected Olmsted County residents matched for age and sex, we developed a conditional logistic regression model appropriate to the matched case-control study design and then estimated attributable risk for the risk factors individually and collectively.
Results: Fifty-nine percent of the cases of venous thromboembolism in the community could be attributed to institutionalization (current or recent hospitalization or nursing home residence). Hospitalization for surgery (24%) and for medical illness (22%) accounted for a similar proportion of the cases, while nursing home residence accounted for 13%. The individual attributable risk estimates for malignant neoplasm, trauma, congestive heart failure, central venous catheter or pacemaker placement, neurological disease with extremity paresis, and superficial vein thrombosis were 18%, 12%, 10%, 9%, 7%, and 5%, respectively. Together, the 8 risk factors accounted for 74% of disease occurrence.
Conclusions: Factors associated with institutionalization independently account for more than 50% of all cases of venous thromboembolism in the community. Greater emphasis should be placed on prophylaxis for hospitalized medical patients. Other recognized risk factors account for about 25% of all cases of venous thromboembolism, while the remaining 25% of cases are idiopathic.
Similar articles
-
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.Arch Intern Med. 2000 Mar 27;160(6):809-15. doi: 10.1001/archinte.160.6.809. Arch Intern Med. 2000. PMID: 10737280
-
Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study.Am J Med. 2018 Mar;131(3):307-316.e2. doi: 10.1016/j.amjmed.2017.09.015. Epub 2017 Oct 4. Am J Med. 2018. PMID: 28987552 Free PMC article.
-
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.Ann Intern Med. 2005 Nov 15;143(10):697-706. doi: 10.7326/0003-4819-143-10-200511150-00006. Ann Intern Med. 2005. PMID: 16287790
-
[Venous thromboembolism prophylaxis].Anaesthesist. 2004 Jul;53(7):657-72; quiz 673. doi: 10.1007/s00101-004-0696-y. Anaesthesist. 2004. PMID: 15292966 Review. German.
-
The epidemiology of venous thromboembolism in the community: implications for prevention and management.J Thromb Thrombolysis. 2006 Feb;21(1):23-9. doi: 10.1007/s11239-006-5572-y. J Thromb Thrombolysis. 2006. PMID: 16475038 Review.
Cited by
-
Combined endovascular interventions for pulmonary embolism at high altitude in Tibet.Front Cardiovasc Med. 2024 Oct 11;11:1384930. doi: 10.3389/fcvm.2024.1384930. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39465135 Free PMC article.
-
Comparison of cost and complications of primary total hip arthroplasty versus oncologic proximal femur replacement.J Orthop. 2024 Sep 10;61:28-36. doi: 10.1016/j.jor.2024.09.009. eCollection 2025 Mar. J Orthop. 2024. PMID: 39386415
-
Risk Stratification and Management of Intermediate- and High-Risk Pulmonary Embolism.J Clin Med. 2024 Sep 20;13(18):5583. doi: 10.3390/jcm13185583. J Clin Med. 2024. PMID: 39337073 Free PMC article. Review.
-
What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate Threshold.medRxiv [Preprint]. 2024 Sep 1:2024.08.30.24312871. doi: 10.1101/2024.08.30.24312871. medRxiv. 2024. PMID: 39252910 Free PMC article. Preprint.
-
Dispensed prescription medications and short-term risk of pulmonary embolism in Norway and Sweden.Sci Rep. 2024 Aug 29;14(1):20054. doi: 10.1038/s41598-024-69637-4. Sci Rep. 2024. PMID: 39209867 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
